Mark W. Womack is BioCina’s Chief Executive Officer, and in his first 9 months at the helm he led BioCina to a 500% YOY increase in sales and a 250% YOY increase in revenue. Following BioCina’s merger with NovaCina in January 2025 (with the combined company retaining the BioCina name), Mr. Womack created a powerful […]
Jason Arcediano brings an impressive 30 years of experience in the biologics industry to BioCina.
Brett Alderson is a veteran leader in the pharmaceutical industry, predominantly working with the manufacturing of sterile injectables. Brett is a determined and thoughtful leader adept at driving business success and leading through transformative change. He is a champion for clients, instilling a client-centric culture, with transparency and helpfulness. He enjoys mentoring and nurturing a
Michael Tsaconas is BioCina’s Vice President and General Manager. Michael is a seasoned executive with more than 20 years experience in pharmaceutical manufacturing of liquids, creams, solid oral dose forms and large molecule drug substance at companies including FH Faulding, Mayne Pharma, Hospira and most recently Pfizer. Michael has worked in the areas of Quality
Jan Bekker is BioCina’s Vice President Business Development and Commercial Operations. Jan is a biopharmaceutical industry professional with over 20 years academic and industry experience with previous roles at Pfizer, Hospira, Centre for Marine Bioproducts Development, Stellenbosch University, and the Queensland University of Technology. Jan’s significant industry experience and technical knowledge allows him to tailor
